Filter By Industry
Filter By Tag

Press Room

BPS Bioscience, Inc. Press releases

1 - 10 of 19 Press Releases

Jun 25, 2015
Identify Histone Demethylase Inhibitors against the largest panel available with BPS Bioscience

Mar 26, 2015
Adding to an already extensive offering of Immunotherapy products, BPS Bioscience, Inc. (BPS) now provides over 15 exclusive biotin-labeled immunotherapy proteins

Dec 09, 2014
BPS Bioscience, Inc. (“BPS”) announces Ebola virus glycoproteins for drug discovery research use.

Sep 23, 2014
BPS Bioscience, Inc. (“BPS”) announces new kits for screening inhibitors of the histone demethylases FBXL10 & FBXL11 and the histone methyltransferase SETDB1. These unique kits join a large portfolio of kits and proteins for epigenetic research.

Aug 13, 2014
BPS Bioscience, Inc. (BPS) is now offering a KEAP1:Nrf2 Inhibitor Screening Assay Kit

Jun 10, 2014
BPS Bioscience, Inc. (BPS) is now offering its newest cell line: the Hippo Pathway TEAD Reporter – MCF7 Cell Line.

May 29, 2014
BPS Bioscience, Inc. (“BPS”) has developed several new assay kits (BTLA:HVEM, CD28:B7-1, and CTLA4:B7-1) and related proteins to advance immunotherapy research.

Apr 23, 2014
BPS Bioscience, Inc. introduces unique EZH2 mutants and 2 new assay kits for screening EZH2 inhibitors

Oct 31, 2013
Unique Portfolio of Proteins and Assay Kits for PD-1-related Research and Drug Discovery

Oct 14, 2013
BPS Bioscience, Inc. (“BPS”) announces the addition of a panel of 6 protease enzymes for identifying small molecule inhibitors of the Hepatitis C virus (HCV). These unique enzymes are also available for custom screening and profiling services.


RSS Feed for BPS Bioscience, Inc. Press Releases